Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) In Vitro and In Vivo

Inflammation

Volumn 38, Issue 4, 2015, Pages 1502-1516

  Lee, Wonhwa ^a,b   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

aspalathin; barrier integrity; endothelium; inflammation; lipopolysaccharide; nothofagin

Indexed keywords

ANTIINFLAMMATORY AGENT; ASPALATHIN; CELL ADHESION MOLECULE; CHALCONE DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOTHOFAGIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; ASPALATHUS; ASPALATHUS LINEARIS; CELL ADHESION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTOXEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LEUKOCYTE MIGRATION; MALE; MEDICINAL PLANT; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ASPALATHUS LINEARIS; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL MOVEMENT; CHALCONES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS;

EID: 84937252261     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0125-1     Document Type: Article

References (78)

1. Russell, J.A. 2006. Management of sepsis. New England Journal of Medicine 355: 1699–1713.
2. Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86: 279–367.
3. Goldblum, S.E., T.W. Brann, X. Ding, J. Pugin, and P.S. Tobias. 1994. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. Journal of Clinical Investigation 93: 692–702.
4. Baluk, P., L.C. Yao, J. Feng, et al. 2009. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. Journal of Clinical Investigation 119: 2954–2964.
5. Varani, J., and P.A. Ward. 1994. Mechanisms of endothelial cell injury in acute inflammation. Shock 2: 311–319.
6. Aird, W.C. 2007. Endothelium as a therapeutic target in sepsis. Current Drug Targets 8: 501–507.
7. Czermak, B.J., M. Breckwoldt, Z.B. Ravage, et al. 1999. Mechanisms of enhanced lung injury during sepsis. American Journal of Pathology 154: 1057–1065.
8. Prior, R.L., and G. Cao. 1999. Antioxidant capacity and polyphenolic components of teas: implications for altering in vivo antioxidant status. Proceedings of the Society for Experimental Biology and Medicine 220: 255–261.
9. Warren, C.P. 1999. Antioxidant effects of herbs. Lancet 353: 676.
10. McKay, D.L., and J.B. Blumberg. 2007. A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia). Phytotherapy Research 21: 1–16.
11. Kazuno, S., M. Yanagida, N. Shindo, and K. Murayama. 2005. Mass spectrometric identification and quantification of glycosyl flavonoids, including dihydrochalcones with neutral loss scan mode. Analytical Biochemistry 347: 182–192.
12. Lee, W., E.J. Yang, S.K. Ku, K.S. Song, and J.S. Bae. 2012. Anticoagulant activities of oleanolic acid via inhibition of tissue factor expressions. BMB Reports 45: 390–395.
13. Hofbauer, R., D. Moser, H. Salfinger, M. Frass, and S. Kapiotis. 1998. Sufentanil inhibits migration of human leukocytes through human endothelial cell monolayers. Anesthesia and Analgesia 87: 1181–1185.
14. Bae, J.S., and A.R. Rezaie. 2011. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118: 3952–3959.
15. Kim, T.H., S.K. Ku, and J.S. Bae. 2011. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food and Chemical Toxicology 50: 1118–1123.
16. Che, W., N. Lerner-Marmarosh, Q. Huang, et al. 2002. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circulation Research 90: 1222–1230.
17. Bae, J.W., and J.S. Bae. 2011. Barrier protective effects of lycopene in human endothelial cells. Inflammation Research 60: 751–758.
18. Kim, T.H., S.K. Ku, I.C. Lee, and J.S. Bae. 2012. Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Reports 45: 200–205.
19. Bae, J.S., W. Lee, and A.R. Rezaie. 2012. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. Journal of Thrombosis and Haemostasis
20. Lee, J.D., J.E. Huh, G. Jeon, et al. 2009. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. International Immunopharmacology 9: 268–276.
21. Fuseler, J.W., D.M. Merrill, J.A. Rogers, M.B. Grisham, and R.E. Wolf. 2006. Analysis and quantitation of NF-kappaB nuclear translocation in tumor necrosis factor alpha (TNF-alpha) activated vascular endothelial cells. Microscopy and Microanalysis 12: 269–276.
22. Thomas, M.J., Q. Chen, C. Franklin, and L.L. Rudel. 1997. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane). Free Radical Biology & Medicine 23: 927–935.
23. Bowry, V.W., and R. Stocker. 1993. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. Journal of the American Chemical Society 115: 6029–6044.
24. Niki, E., M. Saito, Y. Yoshikawa, Y. Yamamoto, and Y. Kamiya. 1986. Oxidation of Lipids, XII. Inhibition of oxidation of soybean phosphatidylcholine and methyl linoleate in aqueous dispersions by uric acid. Bulletin of the Chemical Society of Japan 59: 471–477.
25. Hasinoff, B.B., D. Patel, and K.A. O'Hara. 2008. Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib. Molecular Pharmacology 74: 1722–1728.
26. Ozdulger, A., I. Cinel, O. Koksel, et al. 2003. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19: 366–372.
27. Joubert, E., W.C. Gelderblom, A. Louw, and D. de Beer. 2008. South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides—a review. Journal of Ethnopharmacology 119: 376–412.
28. Berman, R.S., J.D. Frew, and W. Martin. 1993. Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. British Journal of Pharmacology 110: 1282–1284.
29. Goldblum, S.E., X. Ding, T.W. Brann, and J. Campbell-Washington. 1993. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. Journal of Cellular Physiology 157: 13–23.
30. Walton, K.L., L. Holt, and R.B. Sartor. 2009. Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways. American Journal of Physiology. Gastrointestinal and Liver Physiology 296: G601–G611.
31. Mittelstadt, P.R., J.M. Salvador, A.J. Fornace Jr., and J.D. Ashwell. 2005. Activating p38 MAPK: new tricks for an old kinase. Cell Cycle 4: 1189–1192.
32. Schnittler, H.J., S.W. Schneider, H. Raifer, et al. 2001. Role of actin filaments in endothelial cell-cell adhesion and membrane stability under fluid shear stress. Pflügers Archiv 442: 675–687.
33. Friedl, J., M. Puhlmann, D.L. Bartlett, et al. 2002. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100: 1334–1339.
34. Petrache, I., A. Birukova, S.I. Ramirez, J.G. Garcia, and A.D. Verin. 2003. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. American Journal of Respiratory Cell and Molecular Biology 28: 574–581.
35. Komarova, Y.A., D. Mehta, and A.B.. Malik. 2007. Dual regulation of endothelial junctional permeability. Science’s STKE 2007: re8.
36. Dudek, S.M., and J.G. Garcia. 2001. Cytoskeletal regulation of pulmonary vascular permeability. Journal of Applied Physiology 91: 1487–1500.
37. Frenette, P.S., and D.D. Wagner. 1996. Adhesion molecules—Part II: Blood vessels and blood cells. New England Journal of Medicine 335: 43–45.
38. Frenette, P.S., and D.D. Wagner. 1996. Adhesion molecules—Part 1. New England Journal of Medicine 334: 1526–1529.
39. Frijns, C.J., and L.J. Kappelle. 2002. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33: 2115–2122.
40. Ulbrich, H., E.E. Eriksson, and L. Lindbom. 2003. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends in Pharmacological Sciences 24: 640–647.
41. Marui, N., M.K. Offermann, R. Swerlick, et al. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. Journal of Clinical Investigation 92: 1866–1874.
42. Wung, B.S., C.W. Ni, and D.L. Wang. 2005. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. Journal of Biomedical Science 12: 91–101.
43. Lin, W.N., S.F. Luo, C.B. Wu, C.C. Lin, and C.M. Yang. 2008. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway. Toxicology and Applied Pharmacology 228: 256–268.
44. Ruiz-Torres, M.P., G. Perez-Rivero, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and M.L. Diez-Marques. 2006. The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins. Cellular Physiology and Biochemistry 17: 221–232.
45. Javaid, K., A. Rahman, K.N. Anwar, R.S. Frey, R.D. Minshall, and A.B. Malik. 2003. Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1. Circulation Research 92: 1089–1097.
46. Lockyer, J.M., J.S. Colladay, W.L. Alperin-Lea, T. Hammond, and A.J. Buda. 1998. Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circulation Research 82: 314–320.
47. Yamagami, H., S. Yamagami, T. Inoki, S. Amano, and K. Miyata. 2003. The effects of proinflammatory cytokines on cytokine-chemokine gene expression profiles in the human corneal endothelium. Investigative Ophthalmology & Visual Science 44: 514–520.
48. Rose, B.A., T. Force, and Y. Wang. 2010. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiological Reviews 90: 1507–1546.
49. Ajmone-Cat, M.A., R. De Simone, A. Nicolini, and L. Minghetti. 2003. Effects of phosphatidylserine on p38 mitogen activated protein kinase, cyclic AMP responding element binding protein and nuclear factor-kappaB activation in resting and activated microglial cells. Journal of Neurochemistry 84: 413–416.
50. Osmond, R.I., A. Sheehan, R. Borowicz, et al. 2005. GPCR screening via ERK 1/2: a novel platform for screening G protein-coupled receptors. Journal of Biomolecular Screening 10: 730–737.
51. Covert, M.W., T.H. Leung, J.E. Gaston, and D. Baltimore. 2005. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309: 1854–1857.
52. Alderton, W.K., C.E. Cooper, and R.G. Knowles. 2001. Nitric oxide synthases: structure, function and inhibition. Biochemical Journal 357: 593–615.
53. Inoguchi, T., P. Li, F. Umeda, et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939–1945.
54. Wolfe, K.L., and R.H. Liu. 2007. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. Journal of Agricultural and Food Chemistry 55: 8896–8907.
55. Wang, G., Y. Gong, F.J. Burczynski, and B.B. Hasinoff. 2008. Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay. Free Radical Research 42: 435–441.
56. Bae, J.S. 2012. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 35: 1511–1523.
57. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885–891.
58. Bhatia, M., M. He, H. Zhang, and S. Moochhala. 2009. Sepsis as a model of SIRS. Frontiers in Bioscience 14: 4703–4711.
59. Bierhaus, A., J. Chen, B. Liliensiek, and P.P. Nawroth. 2000. LPS and cytokine-activated endothelium. Seminars in Thrombosis and Hemostasis 26: 571–587.
60. Hawiger, J. 2001. Innate immunity and inflammation: a transcriptional paradigm. Immunologic Research 23: 99–109.
61. Marcus, B.C., C.W. Wyble, K.L. Hynes, and B.L. Gewertz. 1996. Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression. Surgery 120: 411–416. discussion 416-417.
62. Beynon, H.L., D.O. Haskard, K.A. Davies, R. Haroutunian, and M.J. Walport. 1993. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clinical and Experimental Immunology 91: 314–319.
63. Sedgwick, J.B., I. Menon, J.E. Gern, and W.W. Busse. 2002. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. Journal of Allergy and Clinical Immunology 110: 752–756.
64. Wei, X.Q., I.G. Charles, A. Smith, et al. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408–411.
65. Cuzzocrea, S., P.K. Chatterjee, E. Mazzon, et al. 2002. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 18: 169–176.
66. Gunnett, C.A., D.D. Lund, A.K. McDowell, F.M. Faraci, and D.D. Heistad. 2005. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 1617–1622.
67. Hauser, B., M. Matejovic, and P. Radermacher. 2008. Nitric oxide, leukocytes and microvascular permeability: causality or bystanders? Critical Care 12: 104.
68. Mollace, V., M. Colasanti, C. Muscoli, et al. 1998. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells. British Journal of Pharmacology 124: 742–746.
69. Wu, C.Y., H.L. Hsieh, M.J. Jou, and C.M. Yang. 2004. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. Journal of Neurochemistry 90: 1477–1488.
70. Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L622–L645.
71. Fiebich, B.L., R.D. Butcher, and P.J. Gebicke-Haerter. 1998. Protein kinase C-mediated regulation of inducible nitric oxide synthase expression in cultured microglial cells. Journal of Neuroimmunology 92: 170–178.
72. Jeon, K.I., X. Xu, T. Aizawa, et al. 2010. Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proceedings of the National Academy of Sciences of the United States of America 107: 9795–9800.
73. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85–94.
74. Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.
75. Borbiev, T., A.D. Verin, A. Birukova, F. Liu, M.T. Crow, and J.G. Garcia. 2003. Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. American Journal of Physiology. Lung Cellular and Molecular Physiology 285: L43–L54.
76. Wadgaonkar, R., L. Linz-McGillem, A.L. Zaiman, and J.G. Garcia. 2005. Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity. Journal of Cellular Biochemistry 94: 351–364.
77. Krafczyk, N., F. Woyand, and M.A. Glomb. 2009. Structure-antioxidant relationship of flavonoids from fermented rooibos. Molecular Nutrition & Food Research 53: 635–642.
78. Snijman, P.W., E. Joubert, D. Ferreira, et al. 2009. Antioxidant activity of the dihydrochalcones Aspalathin and Nothofagin and their corresponding flavones in relation to other rooibos (Aspalathus linearis) flavonoids, epigallocatechin gallate, and Trolox. Journal of Agricultural and Food Chemistry 57: 6678–6684.